Home β€Ί Healthcare β€Ί Biotechnology β€Ί Platelets Rich Plasma Market

Platelets Rich Plasma Market Size, Share, Opportunities, And Trends By Type (Pure Platelet-Rich Plasma, Leukocyte-and Platelet-Rich Plasma, Pure Platelet-Rich Fibrin, Leukocyte- and Platelet-Rich Fibrin), By Source (Autologous, Allogenic, Homologous), By Application (Orthopedic Surgery, Neurosurgery, General Surgery, Others), By End User (Hospitals and Clinics, Research Institutes, Ambulatory Surgical Centers), And By Geography - Forecasts From 2025 to 2030

πŸ“₯ Download Free SampleπŸ’¬ Speak to Analyst
$3,950
Single User License
Access Full Insights
Report OverviewSegmentationTable of ContentsCustomize Report

Report Overview

🎯

Platelets Rich Plasma Market Highlights

Plasma Lighting Market
Plasma Therapy Market
Platelet Function Test Market

Platelets Rich Plasma Market Size:

The Platelets Rich Plasma Market is expected to grow from US$674.599 million in 2025 to US$1,285.833 million in 2030, at a CAGR of 13.77%.

Platelets or thrombocytes are tiny blood cells that form clots or plugs at the site of injury to stop bleeding. They are produced in the bone marrow along with the white and red blood cells.

Blood plasma is the liquid portion of blood in which blood cells are suspended. It acts as a transport medium for delivering nutrients to the cells of the various organs of the body and for transporting waste products derived from cellular metabolism to the kidneys, liver, and lungs for excretion.

Platelets Rich Plasma Market Trends:

The blood platelet and plasma market is expected to show significant growth during the forecast period due to the rising number of patients requiring plasma and platelet transfusion throughout the world, as platelets-plasma blood ensures to quick healing of injuries in bones and soft tissues, which are caused during sports, accidents, and others, as it uses the plasma concentrated out one’s own blood.

The growing use of platelet-rich plasma in various therapeutic areas like during the facelift, hair growth, sports, and orthopedic surgeries will also augment the growth of the market. However, the high cost of plasma therapy and the threats or consequences associated with platelet-rich plasma might restrict the growth of the market during the given time frame.

Platelets Rich Plasma Market Drivers

The rise in the number of cosmetic surgeries.
Increased numbers of accidents in general.

Platelets Rich Plasma Market Restraints

Highly expensive.
This method is still underdeveloped and its effectiveness is still under observation.

The major players profiled in the platelets-rich plasma market include DePuy Synthes, Regen Lab USA LLC, Harvest Technologies, Eclipse, Regenexx, Arthrex, Inc., Grifols International S.A., Bio Product Laboratory Ltd (BPL), Biolife Plasma Services, and Kedrion S.P.A

Platelets Rich Plasma Market Scope:

Report Metric Details
Study Period 2021 to 2031
Historical Data 2021 to 2024
Base Year 2025
Forecast Period 2026 – 2031

 

Report Metric Details
Platelets Rich Plasma Market Size in 2025 US$674.599 million
Platelets Rich Plasma Market Size in 2030 US$1,285.833 million
Growth Rate CAGR of 13.77%
Study Period 2020 to 2030
Historical Data 2020 to 2023
Base Year 2024
Forecast Period 2025 – 2030
Forecast Unit (Value) USD Million
Segmentation
  • Type
  • Source
  • Application
  • End User
  • Geography
Geographical Segmentation North America, South America, Europe, Middle East and Africa, Asia Pacific
List of Major Companies in the Platelets Rich Plasma Market
  • DePuy Synthes
  • Regen Lab USA LLC
  • Harvest Technologies,
  • Eclipse
  • Regenexx
Customization Scope Free report customization with purchase

 

The Platelet Rich Plasma market has been analyzed through the following segments:

By Type

  • Pure Platelet-Rich Plasma (P-PRP) or Leukocyte-Poor Platelet-Rich Plasma
  • Leukocyte-and Platelet-Rich Plasma (L-PRP)
  • Pure Platelet-Rich Fibrin (P-PRF)
  • Leukocyte- and Platelet-Rich Fibrin (L-PRF)

By Source

  • Autologous
  • Allogenic
  • Homologous

By Application

  • Orthopedic Surgery
  • Neurosurgery
  • General Surgery
  • Others

By End User

  • Hospitals and Clinics
  • Research Institutes
  • Ambulatory Surgical Centers

By Geography

  • North America
    • USA
    • Canada
    • Mexico
  • South America
    • Brazil
    • Argentina
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Spain
    • Others
  • Middle East and Africa
    • Saudi Arabia
    • Israel
    • Others
  • Asia Pacific
    • China
    • Japan
    • South Korea
    • India
    • Others

Our Best-Performing Industry Reports:

REPORT DETAILS

Report ID:KSI061612671
Published:May 2025
Pages:148
Format:PDF, Excel, PPT, Dashboard
πŸ“₯ Download SampleπŸ“ž Speak to AnalystπŸ“§ Request Customization

Need Assistance?

Our research team is available to answer your questions.

Contact Us

Frequently Asked Questions

The platelets rich plasma market is expected to reach a total market size of US$1,285.833 million by 2030.

Platelets Rich Plasma Market is valued at US$674.599 million in 2025.

The platelets rich plasma market is expected to grow at a CAGR of 13.77% during the forecast period.

Rising demand for minimally invasive treatments, orthopedic and cosmetic procedures, and increasing sports injuries are driving PRP market growth.

The North American region is anticipated to hold a significant share of the platelets rich plasma market.

Related Reports

Healthcare

Pre-Clinical CRO Market Size, Share, Opportunities, and Trends By Service Type (Toxicology Testing, Pharmacokinetics & Pharmacodynamics, Safety Pharmacology, Bioanalytical Services, In Vitro Testing, In Vivo Models), By Drug Type (Biologics, Vaccines, Small Molecules, Cell/Gene Therapies), By Therapeutic Area (Oncology, CNS Disorders, Infectious Diseases, Cardiovascular Diseases, Metabolic Disorders, Rare Diseases, Others), By End-User (Biotech Startups, Large Pharma, Medical Device Companies, Academic/Government Institutes), And By Geography – Forecasts From 2025 To 2030

May 2025
Healthcare

Clinical CRO Market Size, Share, Opportunities, And Trends By Clinical Phase (Phase I Trials, Phase II Trials, Phase III Trials, Phase IV [Post-Marketing Surveillance]), By Therapeutic Area (Oncology, CNS, Cardiovascular, Infectious Diseases, Immunology, Metabolic Disorders, Rare Diseases, Others), By Service Category (Clinical Operations And Monitoring, Data And Analytics, Regulatory And Safety, Real-World Evidence [RWE] & Health Economics Outcomes Research [HEOR]), By Client Type (Large Pharma, Small & Mid Biotech, Medical Device Companies, Government And Academic Institutes, CDMOs), And By Geography – Forecasts From 2025 To 2030

May 2025
Healthcare

Industrial Biotechnology Market Size, Share, Opportunities, And Trends By Technology (Fermentation, Genetic Engineering, Others), By Raw Materials (Enzymes, Microorganisms, Bacteria, Yeast, Others), By Application (Biofuel, Biopolymer, Biochemicals, Biomedicines, Others), By End-User (Pharmaceutical, Food & Beverage, Chemical, Energy & Power, Textiles, Others), And By Geography – Forecasts From 2025 To 2030

May 2025
Healthcare

Botulinum Toxins Market - Strategic Insights and Forecasts (2025-2030)

Jan 2026
View All Reports